Oncotelic Revenue and Competitors
Estimated Revenue & Valuation
- Oncotelic's estimated annual revenue is currently $3.7M per year.
- Oncotelic's estimated revenue per employee is $169,091
Employee Data
- Oncotelic has 22 Employees.
- Oncotelic grew their employee count by 10% last year.
Oncotelic's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | CMO | Reveal Email/Phone |
3 | Chief Clinical Officer-Translational Medicine | Reveal Email/Phone |
4 | Product Manager | Reveal Email/Phone |
Oncotelic Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Oncotelic?
Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for cancer, covid-19, and other viruses
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.7M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Agoura Hills
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 22 | 10% | N/A |
#2 | $4.1M | 22 | 10% | N/A |
#3 | $3.8M | 22 | -4% | N/A |
#4 | $2M | 22 | -19% | $21.4M |
#5 | $1M | 23 | 28% | $6M |